B. J. Kennedy, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Androgenic hormone increases erythropoiesis when administered in massive doses for a prolonged period. Furthermore, in depression of bone marrow function by toxic agents or disease, improvement of leukopenia and thrombocytopenia have been inconsistently observed.
Androgenic hormones have been administered to patients with advanced malignancies in an attempt to allow chemotherapeutic agents to be employed more effectively. The hormone was administered to patients with (1) depressed marrow due to tumor; (2) depressed marrow due to previous cytotoxic therapy or irradiation therapy; and (3) normal marrow prior to intensive cytotoxic therapy. When the androgenic hormone was administered for more than 6 weeks,
Learn more about subscription options.
Register Now for a free account.
Kennedy BJ. Stimulation of Hematopoiesis by Androgenic Hormone.. Ann Intern Med. 1964;60:327. doi: 10.7326/0003-4819-60-2-327_2
Download citation file:
Published: Ann Intern Med. 1964;60(2_Part_1):327.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only